The Worldwide Regenerative Medicine Industry is Expected to Reach $48.7 Billion by 2027


Dublin, Dec. 22, 2022 (GLOBE NEWSWIRE) -- The "Global Regenerative Medicine Market (2022-2027) by Products, Applications, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

The Global Regenerative Medicine Market is estimated to be USD 19.95 Bn in 2022 and expected to reach USD 48.7 Bn by 2027, growing at a CAGR of 19.54%.

Report AttributeDetails
No. of Pages204
Forecast Period2022 - 2027
Estimated Market Value (USD) in 2022$19.95 Billion
Forecasted Market Value (USD) by 2027$48.7 Billion
Compound Annual Growth Rate19.5%
Regions CoveredGlobal

Market dynamics are forces that impact the prices and behaviors of the Global Regenerative Medicine Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service.

Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding growth and reducing the risks.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are 3M Company, Allergan PLC, Novartis Ag, Smith & Nephew PLC, Stryker Corp., Zimmer Biomet, etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of the Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Regenerative Medicine Market. Ansoff Matrix, also known as the Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development, and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

The analyst analyses the Global Regenerative Medicine Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Regenerative Medicine Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains a competitive analysis using Positioning Quadrants, the analyst's competitive positioning tool.

Key Topics Covered:

1 Report Description

2 Research Methodology

3 Executive Summary

4 Market Dynamics
4.1 Drivers
4.1.1 Increasing Adoption of Stem Cell Technologies, Gene Therapies, and Tissue Engineering
4.1.2 Technological Advancements in Regenerative Medicine Biologics, 3D Bioprinting, And Biomaterials
4.1.3 Product Approval Coupled with Rising Government Investments in Regeneration
4.2 Restraints
4.2.1 Regulatory Issues About Stem Cell, Tissues Engineering, and Regenerative Medicine
4.2.2 High Cost Associated with Treatment
4.3 Opportunities
4.3.1 Growing Demand for Organ Transplantation and Bone Grafting
4.3.2 Increasing R&D Activities by Private Players Coupled with the Involvement of Academic Institutes for Research
4.4 Challenges
4.4.1 Ethical Issues Related to the Use of Embryonic Stem Cells in R&D

5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 PESTLE Analysis
5.4 Impact of COVID-19
5.5 Ansoff Matrix Analysis

6 Global Regenerative Medicine Market, By Products
6.1 Introduction
6.2 Cell-Based Immunotherapy & Cell Therapy Products
6.2.1 Allogeneic Products
6.2.2 Autologous Products
6.3 Gene Therapy Products
6.4 Small Molecule and Biologic
6.5 Tissue-Engineered Products

7 Global Regenerative Medicine Market, By Applications
7.1 Introduction
7.2 Diabetes
7.3 Musculoskeletal Disorders
7.4 Ocular Disorders
7.5 Oncology
7.6 Wound Care
7.7 Cardiovascular

8 Americas' Regenerative Medicine Market
8.1 Introduction
8.2 Argentina
8.3 Brazil
8.4 Canada
8.5 Chile
8.6 Colombia
8.7 Mexico
8.8 Peru
8.9 United States
8.10 Rest of Americas

9 Europe's Regenerative Medicine Market
9.1 Introduction
9.2 Austria
9.3 Belgium
9.4 Denmark
9.5 Finland
9.6 France
9.7 Germany
9.8 Italy
9.9 Netherlands
9.10 Norway
9.11 Poland
9.12 Russia
9.13 Spain
9.14 Sweden
9.15 Switzerland
9.16 United Kingdom
9.17 Rest of Europe

10 Middle East and Africa's Regenerative Medicine Market
10.1 Introduction
10.2 Egypt
10.3 Israel
10.4 Qatar
10.5 Saudi Arabia
10.6 South Africa
10.7 United Arab Emirates
10.8 Rest of MEA

11 APAC's Regenerative Medicine Market
11.1 Introduction
11.2 Australia
11.3 Bangladesh
11.4 China
11.5 India
11.6 Indonesia
11.7 Japan
11.8 Malaysia
11.9 Philippines
11.10 Singapore
11.11 South Korea
11.12 Sri Lanka
11.13 Thailand
11.14 Taiwan
11.15 Rest of Asia-Pacific

12 Competitive Landscape
12.1 Competitive Quadrant
12.2 Market Share Analysis
12.3 Strategic Initiatives
12.3.1 M&A and Investments
12.3.2 Partnerships and Collaborations
12.3.3 Product Developments and Improvements

13 Company Profiles
13.1 3M Company
13.2 Allergan PLC
13.3 Amgen, Inc.
13.4 Anterogen Co., Ltd.
13.5 Aspect Biosystems Ltd.
13.6 bluebird bio, Inc.
13.7 Corestem, Inc.
13.8 Integra LifeSciences Corp.
13.9 Kite Pharma
13.10 MEDIPOST Co., Ltd.
13.11 MiMedx Group
13.12 MISONIX, Inc.
13.13 Novartis Ag
13.14 Organogenesis, Inc.
13.15 Orthocell Ltd.
13.16 Sibiono GeneTech Co. Ltd.
13.17 Smith & Nephew PLC
13.18 Spark Therapeutics, Inc.
13.19 Stryker Corp.
13.20 Takeda Pharmaceutical Co. Ltd.
13.21 Tego Science, Inc.
13.22 Vericel Corp.
13.23 Zimmer Biomet

14 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/cu51db

Attachment

 
Global Regenerative Medicine Market

Contact Data